Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma

被引:4
作者
Mooney, Craig P. [1 ]
Gao, Kan [1 ]
Clark, Jonathan R. [1 ,3 ,4 ]
Gupta, Ruta [1 ,3 ,5 ]
Shannon, Kerwin [1 ]
Palme, Carsten E. [1 ,2 ,3 ]
Ebrahimi, Ardalan [1 ,6 ]
Ch'ng, Sydney [3 ]
Low, Tsu-Hui [1 ,3 ]
机构
[1] Chris OBrien Lifehouse, Sydney Head & Neck Canc Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[3] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia
[4] Sydney Local Hlth Dist, Royal Prince Alfred Inst Acad Surg, Sydney, NSW, Australia
[5] NSW Hlth Pathol, Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia
[6] Australian Natl Univ, Coll Hlth & Med, Med Sch, Canberra, ACT, Australia
关键词
Cutaneous squamous cell carcinoma; head and neck cancer; metastasis; soft tissue metastasis; survival; ORGAN TRANSPLANT RECIPIENTS; NONMELANOMA SKIN-CANCER; IN-TRANSIT METASTASIS; UNITED-STATES; EPIDEMIOLOGY;
D O I
10.1002/lary.29064
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Soft tissue metastases (STM) in head and neck cutaneous squamous cell carcinoma (HNcSCC) are non-nodal based metastases to the parotid and cervical soft tissues of the head and neck. This is a unique subgroup of regional metastases amongst patients with cSCC and have been shown to be associated with poor prognosis. Detailed studies of this subgroup are lacking in the literature. A retrospective cohort analysis was performed to characterize the prognostic significance of STM in HNcSCC based on individual clinicopathological features. Methods Patients with HNcSCC with STM were identified from the Sydney Head and Neck Cancer Institute database. Clinicopathological characteristics were extracted from the histopathological reports. Recurrence and follow-up data were analyzed to determine disease-free and overall survival using the Kaplan-Meier method and Cox proportional hazards models. Results After excluding all patients with lymph node metastasis with no STM, there were 200 patients identified (161 parotid, 32 cervical, and seven with concurrent parotid and cervical STM) with a 5-year overall survival of 36%. In univariable analysis, age of patients, size of the deposits, location of the deposits, and patients that were not offered adjuvant radiotherapy have worse overall survival. However, on multivariable analysis, age and the number of STM deposits were independent factors that predict for worse survival. Conclusion The presence of STM in patients with HNcSCC is associated with poor prognosis. Increasing number of STM deposits, as well as involved margin of the regional excision, negatively impacted on the overall prognosis. Level of Evidence Level III - retrospective cohort study.Laryngoscope, 2020
引用
收藏
页码:E1209 / E1213
页数:5
相关论文
共 50 条
  • [41] Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study
    Ebrahimi, Ardalan
    Gupta, Ruta
    Mcdowell, Lachlan
    Magarey, Matthew J. R.
    Smith, Paul N.
    Schulte, Klaus-Martin
    Perriman, Diana M.
    Veness, Michael
    Porceddu, Sandro
    Low, Tsu-Hui Hubert
    Fowler, Allan
    Clark, Jonathan R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 254 - 262
  • [42] Cutaneous Squamous Cell Carcinoma
    Waldman, Abigail
    Schmults, Chrysalyne
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (01) : 1 - +
  • [43] Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient
    McLaughlin, Eamon J.
    Miller, Lauren
    Shin, Thuzar M.
    Sobanko, Joseph F.
    Cannady, Steven B.
    Miller, Christopher J.
    Newman, Jason G.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2017, 38 (03) : 325 - 328
  • [44] Cutaneous Squamous Cell Carcinoma
    Leiter, U.
    Gutzmer, R.
    Alter, M.
    Ulrich, C.
    Lonsdorf, A. S.
    Sachse, M. M.
    Hillen, U.
    HAUTARZT, 2016, 67 (11): : 857 - 866
  • [45] Number of nodal metastases and the American Joint Committee on cancer staging of head and neck cutaneous squamous cell carcinoma: A multicenter study
    Ebrahimi, Ardalan
    Gupta, Ruta
    Luk, Peter
    Low, Tsu-Hui
    McDowell, Lachlan
    Magarey, Matthew J. R.
    Smith, Paul N.
    Perriman, Diana M.
    Schulte, Klaus-Martin
    Veness, Michael
    Porceddu, Sandro, V
    Clark, Jonathan R.
    ORAL ONCOLOGY, 2020, 111
  • [46] Relevance of Intraparotid Metastases in Head and Neck Skin Squamous Cell Carcinoma
    Duer, Cilgia
    Salmina, Cinzia
    Borner, Urs
    Giger, Roland
    Nisa, Lluis Nisa
    LARYNGOSCOPE, 2021, 131 (04) : 788 - 793
  • [47] Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck
    Ulrich Strassen
    Benedikt Hofauer
    Christian Jacobi
    Andreas Knopf
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 501 - 506
  • [48] Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Iancu, Doriana
    Fulga, Ana
    Vesa, Doina
    Fulga, Iuliu
    Tutunaru, Dana
    Zenovia, Andrei
    Piraianu, Alin Ionut
    Stamate, Elena
    Sterian, Corina
    Dimofte, Florentin
    Badea, Mihail Alexandru
    Tatu, Alin Laurentiu
    CLINICS AND PRACTICE, 2025, 15 (01)
  • [49] Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck
    Fang, Qigen
    Yuan, Junhui
    Zhang, Xu
    Dai, Liyuan
    Luo, Ruihua
    BMC CANCER, 2024, 24 (01)
  • [50] Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma (Review)
    Iancu, Doriana
    Fulga, Ana
    Vesa, Doina
    Zenovia, Andrei
    Fulga, Iuliu
    Sarbu, Mihaela Ionela
    Tatu, Alin Laurentiu
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (06)